These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32285402)

  • 21. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
    Yfantopoulos J; Chantzaras A; Kontodimas S
    Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
    Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
    Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.
    Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN
    Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
    Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
    BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.
    Yfantopoulos JN; Chantzaras AE
    Eur J Health Econ; 2017 May; 18(4):519-531. PubMed ID: 27262480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating an EQ-5D-5L Value Set for China.
    Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
    Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China.
    Liu L; Li S; Wang M; Chen G
    Patient Prefer Adherence; 2017; 11():1049-1056. PubMed ID: 28706443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urban/rural differences in preferences for EQ-5D-5L health states: a study of a multi-ethnic region in China.
    Liao M; Luo N; Rand K; Yang Z
    Qual Life Res; 2023 Aug; 32(8):2329-2339. PubMed ID: 36944783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
    Batt K; Recht M; Cooper DL; Iyer NN; Kempton CL
    Patient Prefer Adherence; 2017; 11():1369-1380. PubMed ID: 28860720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EQ-5D-5L Slovenian population norms.
    Prevolnik Rupel V; Ogorevc M
    Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3 L: a comparison of the 2008 and 2013 National Health Services Surveys.
    Yao Q; Liu C; Zhang Y; Xu L
    Health Qual Life Outcomes; 2019 Mar; 17(1):43. PubMed ID: 30866953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometric properties of the five-level EuroQoL-5 dimension and Short Form-6 dimension measures of health-related quality of life in a population of pregnant women with depression.
    Heslin M; Chua KC; Trevillion K; Nath S; Howard LM; Byford S
    BJPsych Open; 2019 Oct; 5(6):e88. PubMed ID: 31588885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
    Easton T; Milte R; Crotty M; Ratcliffe J
    Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF.
    Purba FD; Hunfeld JAM; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
    PLoS One; 2018; 13(5):e0197098. PubMed ID: 29750806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A; Young CA; Hughes DA
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.